Navigation Links
Advanced Age No Bar to Liver Transplant

Patients over 70 did as well as those in their 50s, study found

THURSDAY, Aug. 23 (HealthDay News) -- Age alone doesn't increase the risk of death among liver transplant patients age 70 or older and shouldn't restrict liver transplantation in the elderly, a new study finds.

A team at the University of California, Los Angeles, David Geffen School of Medicine reviewed the records of 62 patients age 70 and older (average age 71.9 years) and 864 patients ages 50 to 59 (average age 54.3).

All of the patients received their first liver transplant between 1988 and 2005. The patients' survival time was measured until death, the last known follow-up date, or retransplantation.

Overall, 31 of the 62 patients age 70 and older and 345 of the 864 younger patients died during the study period. After one year, 73.3 percent of older patients and 79.4 percent of younger patients were alive. After 10 years, 39.7 percent of older patients and 45.2 percent of younger patients were alive.

According to the researchers, that means they found "no statistically significant difference in survival in the first 10 years after transplantation" between the two groups of patients.

"The longest-surviving patient was 88 years old at 15 years after transplantation. One-year adjusted survival of septuagenarians in the most recent surgical period, 2001 to 2005, was 94.4 percent," the team noted.

The researchers also analyzed 26 variables to determine which ones might predict patient death. They identified four: preoperative hospitalization; prolonged period of cold storage between liver removal and transplantation; cirrhosis caused by hepatitis C and alcohol; and an increasing model for end-stage liver disease (MELD) score, a measure of disease severity.

Being 70 or older was not an independent predictor of death, the authors said.

"In conclusion, biological and physiological variables may play a more important role than advanced age in predicting poor survival after liver transplantation," the UCLA team wrote. "Measures of physiological age and risk of complications should be used in the evaluation process of elderly transplant candidates. Age by itself should not be used to limit liver transplantation."

The study is published in the August issue of the journal Archives of Surgery.

More information

The American Liver Foundation has more about liver transplantation.

-- Robert Preidt

SOURCE: JAMA/Archives journals, news release, Aug. 20, 2007

Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Innovative device aids in advanced heart failure
2. Advanced STD programs required
3. Light therapy devotes new hope in advanced lung cancer
4. Hope For Patients With Advanced Breast Cancer
5. Race an important links to the risk of advanced colorectal cancer
6. HIV Vaccine Field Trials In Advanced Stage
7. Twin Treatment Could Be Used Increase Survival Rates In Advanced Melanoma
8. NICE supports application of advanced biological therapies as treatment option for acute psoriasis
9. Eddie Thompson Receives Advanced Cancer Treatment
10. PSA Can Predicts The Treatment Response In Advanced Prostate Cancer
11. Rapid Aging of Arteries In People With Advanced Heart Disease
Post Your Comments:
(Date:10/13/2017)... N.J. (PRWEB) , ... October 13, 2017 , ... The ... Holly Day Market. Featuring a collection of specialty vendors and unique items from across ... personalized and quality-focused health and wellness services offered by the VNA. The boutique ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned ... Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness ... on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... DIEGO , Oct. 12, 2017 AVACEN ... recognized the company with their  2017 New Product Innovation Award ... based on extensive primary and secondary medical device market research ... Medical, through its first-to-market OTC, drug-free pain relief product, the ... unique approach to treating fibromyalgia widespread pain. ...
(Date:10/11/2017)... Texas , Oct. 11, 2017  True ... services, has amplified its effort during National Breast ... about hereditary cancer risks. ... of Clinical Oncology calculated that more than 10 ... have inherited mutations in BRCA1 or BRCA2 and have ...
(Date:10/5/2017)... Ill. , Oct. 5, 2017  In ... Association of Oral and Maxillofacial Surgeons (AAOMS) released ... opioids – to be used as a first-line ... pain. Recognizing ... the AAOMS White Paper "Opioid Prescribing: Acute and ...
Breaking Medicine Technology: